Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | PTN Palatin Technologies, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $8.87 -2.7% | $16.31 +6.3% |
| StockIQ Score | 43D Weak Risk: High | 42D Weak Risk: Medium |
| Technical | 16F | 36F |
| Fundamental | 30F | 35F |
| Growth | 74B | 50C- |
| Fair Value | 50C- | 38F |
| News | 62C+ | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Palatin Technologies (PTN) outperforms Ascentage Pharma (AAPG) in growth, scoring 74 versus 50, indicating stronger expected expansion. However, AAPG has a higher technical score (36 vs. 16) and slightly better investor sentiment (42 vs. 43). Both carry a "WEAK" rating, but PTN’s valuation score (50) is higher than AAPG’s (38).
